What Is MOTS-C? A Research Overview of the Mitochondrial-Derived Peptide

July 8, 2026

MOTS-C is a 16-amino-acid mitochondrial-derived peptide (MDP) encoded within the mitochondrial 12S rRNA gene rather than in nuclear DNA. It is studied for its links to AMPK-dependent metabolic signalling and cellular energy homeostasis. It is supplied strictly for research use only, and is not for human or veterinary use.

This overview explains what MOTS-C is at a molecular level, how its signalling is understood in preclinical model systems, and why it has become a focus of metabolic, mitochondrial and longevity research. Nothing here describes or implies any human or veterinary application.

What MOTS-C is

MOTS-C stands for Mitochondrial ORF of the 12S rRNA type-C. It is a short peptide of just 16 amino acids and belongs to an emerging class of molecules known as mitochondrial-derived peptides (MDPs). What makes this class distinctive is its origin: rather than being encoded by nuclear DNA like the great majority of the proteome, MOTS-C is encoded within a small open reading frame embedded in the mitochondrial 12S ribosomal RNA (rRNA) gene. In other words, the instructions for the peptide are held in the mitochondrial genome itself.

This origin is more than a taxonomic curiosity. Because the mitochondrion is the principal site of cellular energy production, peptides encoded there are of particular interest as potential signalling molecules that report on, or respond to, the metabolic state of the cell. MOTS-C is characterised in the literature as one such signalling peptide, and in the laboratory it is typically handled as a lyophilised (freeze-dried) powder to be reconstituted for in vitro or preclinical work.

It is worth stating plainly what MOTS-C is not. It is not an incretin, a GLP-1 receptor agonist, or a dual or triple agonist of the kind found among the metabolic peptides that act on gut-hormone receptors. Its mechanism, discussed below, is entirely distinct. At Reta Research it is catalogued under the Mitochondrial category to reflect this.

How it works: AMPK and metabolic signalling

The signalling of MOTS-C is most often discussed in relation to AMPK (AMP-activated protein kinase), a central regulator of cellular energy balance. AMPK is frequently described as a metabolic "fuel gauge": it is activated when the ratio of AMP to ATP rises — that is, when energy is scarce — and its activation is associated in model systems with pathways that restore energy homeostasis.

In preclinical studies, MOTS-C is reported to be associated with AMPK activation, and much of the research interest in the peptide centres on this relationship. Rather than acting through a classical cell-surface receptor cascade of the sort described for incretin peptides, MOTS-C is studied as an intracellular signalling molecule that appears to intersect with the AMPK axis and related metabolic pathways.

A further feature of interest is its behaviour under stress. MOTS-C has been observed to translocate to the nucleus under conditions of metabolic stress, where it is studied for a possible role in influencing adaptive gene expression. This dynamic — a peptide encoded in the mitochondrial genome that can relocate to the nucleus in response to changing energy demands — has made MOTS-C a compelling tool for investigating how mitochondria and the nucleus communicate, a topic sometimes described as retrograde signalling. The overall picture that emerges from the preclinical literature is of a peptide involved in metabolic homeostasis, examined for how it may help cells adapt to shifts in their energy environment.

Why researchers study it

MOTS-C is of research interest across several overlapping fields, and in each case the interest is mechanistic and confined to preclinical and in vitro systems. No therapeutic, clinical, performance or anti-ageing claims are made here, and none should be inferred.

Metabolic research: because of its association with the AMPK axis and energy homeostasis, MOTS-C is studied as a tool for probing how cells sense and respond to their metabolic state.
Mitochondrial-function research: as a mitochondrial-derived peptide, it is of interest for investigating mitochondrial–nuclear communication and the wider biology of the MDP class.
Exercise and mitochondrial-stress research: MOTS-C is examined in preclinical models of metabolic and exercise-related stress, where its reported nuclear translocation offers a way to study adaptive responses.
Longevity research: mitochondrial-derived peptides are a subject of interest in the biology of ageing, and MOTS-C is studied within this preclinical research context.

In each of these areas, the value of MOTS-C lies in what it can reveal about underlying biology. It is used as a research reagent to characterise pathways and mechanisms in model systems, not as an agent with any established application outside the laboratory.

Purity, COA and formats at Reta Research

For laboratory work, the identity and purity of a research peptide matter as much as the sequence on the label. MOTS-C at Reta Research is supplied as a lyophilised powder intended for reconstitution in the laboratory, and each batch is accompanied by documentation so that researchers can verify what they are working with.

Our approach to analytical verification is described on the Quality Testing page, which outlines the methods used to assess identity and purity. A corresponding Certificate of Analysis (COA) is made available so that the reported purity and analytical results can be reviewed before material is used in any assay. Checking the COA against your own experimental requirements is good practice for reproducible research.

As with everything in our catalogue, MOTS-C is offered for research use only and is not for human or veterinary use.

Frequently asked questions

Is MOTS-C a GLP-1 peptide?

No. MOTS-C is a mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA gene, and it is neither an incretin nor a GLP-1 receptor agonist. Its signalling is studied in relation to the AMPK axis and mitochondrial metabolism rather than gut-hormone receptors, which places it in a different category entirely from peptides such as semaglutide, tirzepatide or retatrutide.

What is AMPK's role in MOTS-C research?

AMPK (AMP-activated protein kinase) is a central regulator of cellular energy balance, activated when energy is scarce. In preclinical studies MOTS-C is associated with AMPK activation, and this relationship is one of the main reasons the peptide is studied. It offers researchers a tool for investigating how the AMPK-linked pathways that govern metabolic homeostasis are engaged in model systems.

What sizes are available?

MOTS-C is offered in vial presentations intended for different research scales. The current formats and their specifications are listed on the MOTS-C product page, which is kept up to date with available options.

Is it third-party tested?

Analytical verification is central to how the material is supplied. Details of the testing methodology are set out on our Quality Testing page, and a Certificate of Analysis is provided so the reported results can be reviewed prior to use.